Dr Martin Woodle is CEO of the company. Dr. Martin C. Woodle has 30 years experience in pharmaceutical research and development and currently is co-founder and President of VaxTecBio, developing advanced nanoparticle vaccine technology for infectious disease and cancer as well as Norwood Nano Tech developing gene-function reagents and therapeutics. Most recently Dr. Woodle co-founded Aparnabio, and previously founded Intradigm Corp. as CEO to commercialize Novartis Synthetic Gene Vector technology. He led financing of Intradigm of over $20 million by top tier venture funds including Frazier Healthcare Ventures, Alta Partners, MediBic, Genenfunds, and Novartis Venture Fund, and development of the first efficacious siRNA in primates and murine cancer models.
Dr Kango is founder and president of the company. He has a 30 years experience in wide variety of product and assay development. Worked as a team leader in the development of Cat-GC platform (DARPA), Team leader early lung cancer detection technology under CRADA with NIH. Developed and patented technologies for SPR Platform Chips. Extensive experience in vaccine and biological developments for infectious diseases. More than 15 years of experience providing technology services and implementation at HiTech to key clients in US on variety and diverse projects.
Dr. Archibald J. Mixson is a faculty with University of Maryland Medical School and is Board Certified Internist. Dr Mixson is father of nano medicine and drug delivery. He has several patents and has published widely on this subject. His patented inventions include vaccine and a method for immune activation which is effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in a mammal and other patented inventions includeing siRNA molecules and compositions containing them that inhibit the expression of one or more genes that promote pathological or undesired processes in wound healing besides many other land mark inventions.
Dr. Asif Qadri, MD, is a Cardiovascular Disease specialist practicing in Silver Spring, MD with 55 years of experience. Dr Qadri is a world class well respected cardiologist and has taught cardiology seminars to residents at different programs. Dr Qadri is Founder and Director of MCC clinic one of the largest charitable Medical Clinic on east coast of USA. Clinic has provided services to more than 15,000 patients and around 100,000 patient encounters are recorded. Under his leadership clinic has been able to secure funding from many prestigious organizations like Kaiser Permanente, Susan G. Komen Foundation, Healthcare Initiative Foundation, Maryland State and Montgomery County. He has been honored by many local and national organizations.
Dr. Fazal is an industry leader who served as Vice president of several biotech and biopharma companies including Human Genome Sciences worked as Senior Vice president at very senior level and was part of the team raising 1.5 billion dollars. Senior Vice President of Manufacturing Operations at Merrimack, Inc.. Senior Vice President of Manufacturing Operations at Merrimack, Inc and was responsible getting FDA approval of a drug for Pancreatic cancer. He served as a senior director at Director of Biopharmaceutical Development and Manufacturing at Hoffmann-LaRoche, Inc in his early career. Recently he incepted Advanced Bioanalytical Systems which was sold for an undisclosed amount of money.
Dr. Khan is a Professor of Microbiology, Immunology and Tropical Medicine at The George Washington University Washington, DC. Prof Khan is an outstanding professor of vaccines, biologicals and Immuno therapy. He has around one hundred publications and book chapters. His group has been studying development of CD8+ T cell immunity against parasitic infections for past 25 years and through their pioneering work, Dr. Khan's laboratory demonstrated the role of CD8+ T cells, perforin-mediated cytotoxicity and cytokines in protection against the pathogen. Their research has further focused on the gut immune response against this pathogen, which is a highly understudied area. Dr Khan's research interests also include molecular mechanism of vaccine immunogenecity and efficacy.
Dr Haji is a cardiology super specialist. Recently Chief of Cardiology Martinsburg, VA Medical Hospital , VA. Served in several medical programs as cardiology faculty in New York and Ohio. Dr Haji has keen interest in personalized medicine , its development, applications and future.